Latest Castle Biosciences Inc Stories
New DecisionDx-EC multi-analyte test data presented at ASCO 2014 CHICAGO, May 31, 2014 /PRNewswire/ -- Castle Biosciences Inc.
DecisionDx-Melanoma identifies patients with negative sentinel lymph node biopsies who are at high risk of metastasis FRIENDSWOOD, Texas, May 14, 2014 /PRNewswire/ -- Castle Biosciences Inc.
Enables physicians to pursue more effective treatment plans for patients who are chemoradiation resistant CHICAGO, May 6, 2014 /PRNewswire/ -- Castle Biosciences Inc.
Presentation at the American Association for Thoracic Surgery 94th Annual Meeting TORONTO, April 29, 2014 /PRNewswire/ -- Castle Biosciences Inc.
Data presented at the Latest in Dermatology Research Symposia session of 72nd Annual Meeting of the American Academy of Dermatology DENVER, March 22, 2014 /PRNewswire/ -- Castle Biosciences
Program goal is improved understanding of individual risk for recurrence in patients diagnosed with early stage melanoma FRIENDSWOOD, Texas, Feb.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.